MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $45,000 | -48.3% | 14,745 | -30.5% | 0.00% | -57.1% |
| Q4 2016 | $87,000 | -35.6% | 21,203 | -15.6% | 0.01% | -12.5% |
| Q2 2016 | $135,000 | +58.8% | 25,128 | +147.9% | 0.01% | +60.0% |
| Q1 2016 | $85,000 | -27.4% | 10,138 | -31.3% | 0.01% | -28.6% |
| Q4 2015 | $117,000 | -28.7% | 14,760 | +7.0% | 0.01% | -12.5% |
| Q1 2015 | $164,000 | -33.3% | 13,795 | -59.0% | 0.01% | -46.7% |
| Q2 2014 | $246,000 | – | 33,677 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 1,560,530 | $17,634,000 | 4.71% |
| B & T Capital Management DBA Alpha Capital Management | 280,113 | $3,165,000 | 2.22% |
| Schonfeld Group Holdings LLC | 10,000 | $113,000 | 1.51% |
| COLUMBIA CAPITAL LLC | 117,702 | $1,331,000 | 1.45% |
| Portolan Capital Management | 607,288 | $6,862,000 | 1.38% |
| Price Capital Management, Inc. | 118,047 | $1,334,000 | 1.18% |
| GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,025,000 | 0.93% |
| Opus Point Partners Management, LLC | 72,009 | $814,000 | 0.80% |
| EAM Investors, LLC | 412,233 | $4,658,000 | 0.65% |
| TFS CAPITAL LLC | 476,105 | $5,380,000 | 0.51% |